100 related articles for article (PubMed ID: 26122232)
1. EXPRESSION MECHANISM AND CLINICAL SIGNIFICANCE OF NOB1 IN GASTRIC CANCER TISSUE AND ADJACENT NORMAL TISSUE.
Zhou WP; Liu X; Yang Y; Liu YF
J Biol Regul Homeost Agents; 2015; 29(2):423-30. PubMed ID: 26122232
[TBL] [Abstract][Full Text] [Related]
2. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
Qi H; Wang Y
Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
[TBL] [Abstract][Full Text] [Related]
3. [Increased expression of the c-Met receptor mRNA in gastric cancer].
Amemiya H; Peña A; Chiurillo M; Moscoso J; Useche A; Baffi R
Invest Clin; 2013 Sep; 54(3):284-98. PubMed ID: 24354242
[TBL] [Abstract][Full Text] [Related]
4. Expression of the NOB1 gene and its clinical significance in papillary thyroid carcinoma.
Lin S; Meng W; Zhang W; Liu J; Wang P; Xue S; Chen G
J Int Med Res; 2013 Jun; 41(3):568-72. PubMed ID: 23685895
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
[TBL] [Abstract][Full Text] [Related]
6. Nuclear or cytoplasmic localization of Bag-1 distinctly correlates with pathologic behavior and outcome of gastric carcinomas.
Zheng HC; Xu XY; Xing YN; Wei ZL; Takahashi H; Masuda S; Takano Y
Hum Pathol; 2010 May; 41(5):724-36. PubMed ID: 20096920
[TBL] [Abstract][Full Text] [Related]
7. Positive nin one binding protein expression predicts poor outcome in prostate cancer.
Chen J; Wang J; Cui X; Liu Y; Yin L; Li Y; Chen L; Xu D; Gao Y
Mol Med Rep; 2015 Apr; 11(4):2671-6. PubMed ID: 25503472
[TBL] [Abstract][Full Text] [Related]
8. Abnormal expression of early growth response 1 in gastric cancer: association with tumor invasion, metastasis and heparanase transcription.
Zheng L; Pu J; Jiang G; Weng M; He J; Mei H; Hou X; Tong Q
Pathol Int; 2010 Apr; 60(4):268-77. PubMed ID: 20403028
[TBL] [Abstract][Full Text] [Related]
9. The expression and location of midkine in gastric carcinomas of Chinese patients.
Huang Y; Cao G; Wang H; Wang Q; Hou Y
Cell Mol Immunol; 2007 Apr; 4(2):135-40. PubMed ID: 17484808
[TBL] [Abstract][Full Text] [Related]
10. [Expression of NOB1 and its significance in colorectal cancer].
Wu DP; He XW
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):420-2. PubMed ID: 22445998
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
[TBL] [Abstract][Full Text] [Related]
12. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
[TBL] [Abstract][Full Text] [Related]
13. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer.
Zhang XM; Zhou C; Gu H; Yan L; Zhang GY
Int J Clin Exp Pathol; 2014; 7(9):5902-8. PubMed ID: 25337233
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor-C in gastric carcinoma and the effect of its antisense gene transfection on the proliferation of human gastric cancer cell line SGC-7901.
Zhu P; Zhang J; Chen Q; Wang J; Wang Y
Am J Surg; 2012 Jul; 204(1):78-83. PubMed ID: 22227171
[TBL] [Abstract][Full Text] [Related]
15. NOB1 in non-small-cell lung cancer: expression profile and clinical significance.
Liu K; Gu MM; Chen HL; You QS
Pathol Oncol Res; 2014 Apr; 20(2):461-6. PubMed ID: 24272676
[TBL] [Abstract][Full Text] [Related]
16. High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes.
Liu K; Chen HL; Wang S; Gu MM; Chen XM; Zhang SL; Yu KJ; You QS
Sci Rep; 2016 Jun; 6():28666. PubMed ID: 27346559
[TBL] [Abstract][Full Text] [Related]
17. PROX1 expression in gastric cancer: from hypothesis to evidence.
Taban O; Cimpean AM; Raica M; Olariu S
Anticancer Res; 2014 Jul; 34(7):3439-46. PubMed ID: 24982352
[TBL] [Abstract][Full Text] [Related]
18. [Alteration of early growth response 1 expression in gastroenterological cancers and its biological significance].
An J; Guo RF; Zhang L; Geng PL; Lü YY
Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1384-9. PubMed ID: 18953875
[TBL] [Abstract][Full Text] [Related]
19. Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.
Tang HL; Hu YQ; Qin XP; Jazag A; Yang H; Yang YX; Yang XN; Liu JJ; Chen JM; Guleng B; Ren JL
J Gastroenterol Hepatol; 2012 Aug; 27(8):1395-404. PubMed ID: 22497484
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.
Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z
Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
